Literature DB >> 32492162

Dose-Response Association of Low-Intensity and Nondaily Smoking With Mortality in the United States.

Maki Inoue-Choi1, Carol H Christensen2, Brian L Rostron2, Candace M Cosgrove3, Carolyn Reyes-Guzman4, Benjamin Apelberg2, Neal D Freedman1.   

Abstract

Importance: An increasing proportion of US smokers smoke at low intensity and not every day. Some nondaily smokers have always had this pattern, whereas others previously smoked daily. The effect of reducing the level of smoking from daily to nondaily smoking and the dose response at low smoking levels are poorly understood. Objective: To evaluate risk of all-cause and cause-specific mortality among nondaily and daily cigarette smokers, by cigarettes per month, years after reducing from daily to nondaily smoking, and years since quitting. Design, Setting, and Participants: A prospective cohort study using harmonized data from multiple cycles of the Tobacco Use Supplements to the Current Population Survey (TUS-CPS), linked to the National Death Index, were analyzed during the period from 2018 to 2020. Adults completed the 1992-1993, 1995-1996, 1998-1999, 2000, 2001-2002, 2003, 2006-2007, or 2010-2011 TUS-CPS. Cigarette smokers were classified as daily or nondaily users; current nondaily smokers were further categorized by whether they previously smoked every day. Main Outcomes and Measures: Hazard ratios (HRs) and 95% CIs for risks of mortality vs never smoking. Age was the underlying time metric, adjusted for sex, race/ethnicity, education, survey year, and household income.
Results: Among 505 500 participants (aged 18-103 years), approximately 47 000 deaths occurred. The median number of cigarettes smoked per month was 600 (interquartile range, 300-600) (20 cigarettes per day [interquartile range, 10-20 cigarettes per day]) for daily cigarette smokers and 40 (interquartile range, 15-90) for lifelong nondaily smokers. Nevertheless, both current daily (HR, 2.32; 95% CI, 2.25-2.38) and lifelong nondaily (HR, 1.82; 95% CI, 1.65-2.01) smokers had higher all-cause mortality risks than never smokers. Associations were observed for 6 to 10 cigarettes per month and increased with greater-intensity use. Nondaily smokers who previously smoked every day had lower mortality risks than daily smokers, with similar HRs after 10 or more years of nondaily smoking as lifelong nondaily smokers (HR vs never smokers, 1.73; 95% CI, 1.56-1.92). Yet, their risks were higher than former smokers who quit 10 or more years before (HR vs never smokers, 1.18; 95% CI, 1.15-1.22). Conclusions and Relevance: Although reducing smoking from daily to nondaily was associated with decreased mortality risk, cessation was associated with far greater benefit. Lifelong nondaily smokers have higher mortality risks than never smokers, even among those smoking 6 to 10 cigarettes per month. Thus, all smokers should quit, regardless of how infrequently they smoke.

Entities:  

Year:  2020        PMID: 32492162     DOI: 10.1001/jamanetworkopen.2020.6436

Source DB:  PubMed          Journal:  JAMA Netw Open        ISSN: 2574-3805


  20 in total

Review 1.  Harm reduction for smokers living with HIV.

Authors:  Jonathan Shuter; Krishna P Reddy; Emily P Hyle; Cassandra A Stanton; Nancy A Rigotti
Journal:  Lancet HIV       Date:  2021-08-27       Impact factor: 16.070

2.  Disposable E-Cigarette Use Prevalence, Correlates, and Associations With Previous Tobacco Product Use in Young Adults.

Authors:  Adam M Leventhal; Hongying Dai; Jessica L Barrington-Trimis; Alayna P Tackett; Eric R Pedersen; Denise D Tran
Journal:  Nicotine Tob Res       Date:  2022-02-14       Impact factor: 5.825

3.  Effects of Health-Related Behaviors and Changes on Successful Aging among Indonesian Older People.

Authors:  Lisa Wahidatul Oktaviani; Hui-Chuan Hsu; Yi-Chun Chen
Journal:  Int J Environ Res Public Health       Date:  2022-05-13       Impact factor: 4.614

4.  What Is or What Is Not a Risk Factor for Arterial Hypertension? Not Hamlet, but Medical Students Answer That Question.

Authors:  Tomasz Sobierajski; Stanisław Surma; Monika Romańczyk; Krzysztof Łabuzek; Krzysztof J Filipiak; Suzanne Oparil
Journal:  Int J Environ Res Public Health       Date:  2022-07-05       Impact factor: 4.614

5.  Tobacco and Nicotine Use Among US Adult "Never Smokers" in Wave 4 (2016-2018) of the Population Assessment of Tobacco and Health Study.

Authors:  Elias M Klemperer; John R Hughes; Peter W Callas; Julia C West; Andrea C Villanti
Journal:  Nicotine Tob Res       Date:  2021-06-08       Impact factor: 4.244

6.  Low-intensity daily smoking and cause-specific mortality in Mexico: prospective study of 150 000 adults.

Authors:  Blake Thomson; Roberto Tapia-Conyer; Ben Lacey; Sarah Lewington; Raúl Ramirez-Reyes; Diego Aguilar-Ramirez; Louisa Gnatiuc; William G Herrington; Jason Torres; Eirini Trichia; Rachel Wade; Rory Collins; Richard Peto; Pablo Kuri-Morales; Jesus Alegre-Díaz; Jonathan R Emberson
Journal:  Int J Epidemiol       Date:  2021-07-09       Impact factor: 7.196

7.  Targeted smoking cessation for dual users of combustible and electronic cigarettes: a randomised controlled trial.

Authors:  Ursula Martinez; Vani N Simmons; Steven K Sutton; David J Drobes; Lauren R Meltzer; Karen O Brandon; Margaret M Byrne; Paul T Harrell; Thomas Eissenberg; Christopher R Bullen; Thomas H Brandon
Journal:  Lancet Public Health       Date:  2021-07

8.  E-cigarettes for smoking reduction: a piece of the public health puzzle.

Authors:  Kelvin Choi; Thomas A Wills; Maki Inoue-Choi
Journal:  Lancet Respir Med       Date:  2021-04-12       Impact factor: 102.642

9.  Concentrations of Cotinine and 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol (NNAL) in U.S. Non-Daily Cigarette Smokers.

Authors:  Daniela S Gutiérrez-Torres; Lanqing Wang; Benjamin C Blount; Baoyun Xia; Connie S Sosnoff; Meredith S Shiels; Maki Inoue-Choi; Arash Etemadi; Neal D Freedman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-03-18       Impact factor: 4.090

10.  A comparison of tobacco product prevalence by different frequency of use thresholds across three US surveys.

Authors:  Luz María Sánchez-Romero; Christopher J Cadham; Jana L Hirschtick; Delvon T Mattingly; Beomyoung Cho; Nancy L Fleischer; Andrew Brouwer; Ritesh Mistry; Stephanie R Land; Jihyoun Jeon; Rafael Meza; David T Levy
Journal:  BMC Public Health       Date:  2021-06-24       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.